CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Chief Medical Officer sold 56,726 shares at an average $26.94 ($1,528,324)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 34,600 shares at an average $22.08 ($764,002)
- 4 Open-market sale Chief Medical Officer sold 19,175 shares at an average $19.18 ($367,745)
- 4 Open-market sale Vice President, Finance sold 1,844 shares at $17.77 ($32,768)
- 4 Open-market sale Chief Medical Officer sold 14,975 shares at $18.14 ($271,681)
- 4 Open-market sale Chief Medical Officer sold 4,200 shares at $18.04 ($75,786)
- 4 Grant or award Vice President, Finance acquired 16,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 45,000 shares (grant or award)
- 4 Grant or award President and COO acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 22,300 shares at an average $19.20 ($428,050)
- 4 Open-market sale Chief Medical Officer sold 43,800 shares at an average $22.74 ($995,874)
Page 10 of 16 · 301 filings